Xylem Q4 Adjusted EPS, Revenue Increase-March 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Xylem Q4 Adjusted EPS, Revenue Increase

Feb 4, 2025 4:43 AM

07:19 AM EST, 02/04/2025 (MT Newswires) -- Xylem (XYL) reported Q4 adjusted earnings Tuesday of $1.18 per diluted share, up from $0.99 a year earlier.

Analysts polled by FactSet expected $1.12.

Revenue for the quarter ended Dec. 31 was $2.26 billion, up from $2.12 billion a year earlier.

Analysts surveyed by FactSet expected $2.18 billion.

The company said it expects full-year 2025 revenue of about $8.6 billion to $8.7 billion.

Analysts polled by FactSet expect $8.82 billion.

Previous page： US House panel subpoenas tech giants over foreign communications Next page： Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US House panel subpoenas tech giants over foreign communications

Feb 27, 2025

WASHINGTON, Feb 27 (Reuters) - The U.S. House Judiciary Committee has subpoenaed eight major technology companies, including Alphabet, Meta, Apple ( AAPL ) and X Corp, seeking details about their communications with other countries regarding compliance with laws impacting speech, it said on Thursday. House Judiciary Committee Chairman Jim Jordan, a Republican, sent the subpoenas on Wednesday and also included...

Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise

Feb 27, 2025

09:41 AM EST, 02/27/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) shares were up 1.7% in early trading Thursday after the company reported a Q4 net loss of $0.88 per diluted share, compared with a $1.09 loss a year earlier. Analysts polled by FactSet expected a $0.94 loss. The company did not report revenue for the quarter ended Dec....

Xencor's Q4 Net Loss Widens, Revenue Rises

Feb 27, 2025

09:43 AM EST, 02/27/2025 (MT Newswires) -- Xencor ( XNCR ) reported a Q4 net loss of $0.62 per diluted share, wider than its loss of $0.43 year earlier. Analysts surveyed by FactSet expected a loss of $0.78. Revenue for the quarter ended Dec. 31 was $52.8 million, compared with $51 million a year earlier. Analysts surveyed by FactSet expected...

Teleflex to Separate into Two Publicly Traded Firms -- Shares Fall

Feb 27, 2025

09:42 AM EST, 02/27/2025 (MT Newswires) -- Teleflex ( TFX ) said Thursday its board has authorized its management to pursue a plan to separate the Urology, Acute Care, and OEM segments into a publicly traded company. The deal is expected to be via a distribution of newly issued shares of NewCo to shareholders that will be tax-free for US...